Crossmark

A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma

Crossref DOI link: https://doi.org/10.1039/D0NH00077A

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Kang, Rae Hyung

Jang, Jeong-Eun

Huh, Eugene

Kang, Seong Jae https://orcid.org/0000-0003-0982-3604
Ahn, Dae-Ro https://orcid.org/0000-0001-7108-5855
Kang, Jae Seung

Sailor, Michael J. https://orcid.org/0000-0002-4809-9826
Yeo, Seung Geun

Oh, Myung Sook https://orcid.org/0000-0001-8189-4066
Kim, Dokyoung https://orcid.org/0000-0002-7756-3560
Kim, Hyo Young
Funding

Funding for this research was provided by:

National Institutes of Health (#1R01CA214550-01)

National Research Foundation of Korea (2013-R1A6A3A01064606, 2015-R1A6A3A04059360, 2017-R1A5A2014768, 2018-M3A9H3021707, 2018-R1A6A1A03025124, 2018-R1D1A1B07043383)
License Information

Accepted Manuscript valid from 2021-06-02
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Seong Jae Kang (ORCID)

: Dae-Ro Ahn (ORCID)

: Michael J. Sailor (ORCID)

: Michael J. Sailor (ResearcherID)

: Myung Sook Oh (ORCID)

: Dokyoung Kim (ORCID)

: Dokyoung Kim (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 4 February 2020; Accepted 2 June 2020; Accepted Manuscript published 2 June 2020; Advance Article published 8 June 2020; Version of Record published 27 July 2020